⚠️ Event Postponement Notice ⚠️ CANCELLED TOMORROW! Due to the forecast of very high winds in Barcelona, tomorrow's session at the @www.pcb.ub.edu has been #cancelled. The session has been #rescheduled for *April 22nd*. Stay safe! 🏠💨 www.eventbrite.es/e/aiml-enabl...

Happy International Day of #Women and #Girls in #Science! ✨ Today, we celebrate the scientific vision & contribution of all women in science. We particularly want to thank those at #Chemotargets, whose leadership drives our mission forward and is central to our research and development efforts 💪 🚀

⏳ Only one week left—and tickets are running out! 🚀 Join us at the @www.pcb.ub.edu next February 12th at 09h! This event is completely free & open to everyone, including those from outside the PCB community. We look forward to seeing you there! 👉 www.eventbrite.es/e/aiml-enabl...

New #SafetyVista version ✨ Augmented Safety Intelligence. Proactive Pharmacovigilance. SV offers now a set of unique analytics tools to assist in the detection, analysis and forecast of drug safety signals in both global & stratified patient (sub)populations. Interested? 👉 [email protected]

🗓️ Save the date! We are pleased to announce that we will be presenting at the @www.pcb.ub.edu on Feb. 12 at 9AM. 💊 This event is #free and #open to the general public! See you there! 👉 Registration: www.eventbrite.es/e/aiml-enabl...

Chemotargets is heading to #4YFN! 🚀 📍 Save the date: March 2nd – 5th, 2026

✨ ✨ Season’s greetings to our clients, partners, and friends across the scientific community! May 2026 bring you continued success, health, and plenty of new opportunities for innovation. #HappyHolidays #TeamChemotargets #2026Goals

New Full Professor Prof. Jordi Mestres @univgirona.bsky.social @dimocat-iqcc.bsky.social @chemotargets.com www.udg.edu/ca/instituts...

We’ve successfully concluded the second day of #DDCEurope! While our time as exhibitors has ended, the insightful presentations and discussions continue tomorrow, Thursday, November 13th. Huge thanks to everyone who stopped by our booth and connected with our team! 👏

Day 1 at #DDCEurope is a go! 🎉 The Chemotargets crew has officially landed and we’re getting the party started by #sponsoring the Welcome Reception this evening. Come hang out and say hi—you can find us anytime at #Booth5! #DDCE2025 #DrugDiscovery #AI #ML #Networking #team

All set up at #Booth5! 🚀 👉 www.drugdiscoverychemistry.com/europe/progr... #DDCEurope #DDCE2025 #DrugDiscovery #team #ready

We are proud to share that our outstanding #team will present 3 research posters at the #DDCEurope2025! 🔝 Posters #B01, #B02, and in collaboration with @iqccudg.bsky.social, #A18. 👉 www.drugdiscoverychemistry.com/europe/poste...

#DDCEurope2025 kicks off in less than two weeks, and the Chemotargets team is ready! 🚀 Step by #Booth5 where our experts will be looking forward to meeting you and exploring future collaborations. 👉 ciifloorplan.my.canva.site/dce25 Let's connect & discuss the future of AI-driven drug discovery!

#AssayInspector: a must-have open tool to assess the risk of directly aggregating data from different sources before constructing ML models. Full article: 📖 jcheminf.biomedcentral.com/articles/10.... #DataQuality #DataIntegration #DataHeterogeneity #ModelQuality #ADME #PreclinicalSafety #NAMs

We are thrilled to announce that #Chemotargets will be #sponsoring and #exhibiting at the Drug Discovery Chemistry Europe 2025, which kicks off in Barcelona in three weeks. Stay tuned for the full details! 🚀 👉 More info: www.drugdiscoverychemistry.com/europe #DDCEurope #DDC2025 #DrugDiscovery

At the 2025 #REMEDi4ALL Hackathon near Montserrat, 14 early career researchers from 10 countries joined experts to tackle real-world #DrugRepurposing challenges in rare neurodevelopmental disorders. Read the full event summary and discover who won here➡️https://loom.ly/N6tXCHs

Congratulations! #Jordi_Mestres ✨🔝

This week, our representive #Nikola_Panajotovikj, is attending the 2025 #REMEDi4ALL Hackathon. He will present how #SafetyVista (safety-vista.com) can be used to explore postmarketing drug safety data and drug-target affinities.💊 👉 remedi4all.org/event/2025-r...

Come meet us at #BIOSPAIN2025! We are excited to confirm our participation in one of Europe’s leading biotechnology events. Connect with #Jordi_Mestres through the #partneringONE® platform, and let's explore partnership possibilities! ✨ 👉 biospain.com

Next week, #Jordi_Mestres will be an invited speaker at the #BostonDOT, one of the industry's preeminent event on novel drug targets and technologies. 🚀 👉 www.discoveryontarget.com/ai-ml-enable... We look forward to his contribution to this prestigious event! #DiscoveryOnTarget #Boston #AI #ML

This week we present #FragSteer; the D3 agent that takes the output of #SurfScan and rank orders all chemical fragments based on the external force required to get them out of the protein cavity using a customised steer MD implementation. Contact us at #[email protected] for more information!

Today we introduce #SurfScan, the D3 agent that fills protein cavities with chemical fragments known to bind in protein environments similar to those exposed by the target cavity. Contact us at #[email protected] for more information on collaborative and partnering opportunities. #AIDD

**Postdoc Research Position** #available in "AI/ML Approaches to Precision Drug Discovery" @iqccudg.bsky.social @univgirona.bsky.social Interested candidates please contact: [email protected] #fragmentscreening #generativechemistry #drugresistance #precisionmedicine

Get now your free access to CAS BioFinder™ for a limited time! Enjoy full access to the CAS BioFinder Discovery Platform™, seamlessly integrated with your CAS SciFinder® experience. www.cas.org/lp/biofinder...

#CIPsee (cipsee.com) just got even more powerful! 🚀 Request full access to the #new features that bring deeper insight to your patent analysis. Contact us at #[email protected] to sign in and start looking at chemical intellectual property from a different lens.

💊 The International Drug Repurposing Conference #iDR25 has started in Amsterdam. #Chemotargets will be represented by Nikola Panajotovikj, exploring with the drug repurposing community ways to unlock the potential of existing drugs for the benefit of patients. 👉 lnkd.in/eb32WZd5 #iDR25 #R4ALL

A new AI-powered version of #SafetyVista has just been released, now including 2M+ LLM-assisted drug-safety data points from 25K clinical trials and 2K congress abstracts. 🚀 👉 safety-vista.com #DrugSafety #SignalDetection #LLMs #MLmodeling #pharmacovigilance

Just one week left for the 2025 International #DrugRepurposing conference #iDR25!! As a partner of the #R4ALL project, #Chemotargets will be there represented by Nikola Panajotovikj. 👉 remedi4all.org/2025-interna... #REMEDi4ALL #EATRIS #BeaconforRareDiseases #DrugRepurposing #HorizonEU

🔹 #UdGActualitat | La UdG i Chemotargets s’alien per donar una segona vida a molècules oblidades als laboratoris. www.udg.edu/ca/udg/detal...

We are thrilled to announce that @dimocat-iqcc.bsky.social, @univgirona.bsky.social and #Chemotargets sign a strategic #alliance to give a second life to all small molecules synthesised during the last three decades. 🚀 🔎 Press release: www.udg.edu/ca/instituts...

IQCC-UdG and Chemotargets join forces to give a second life to forgotten molecules in the laboratory #IndustryQCC @univgirona.bsky.social @dimocat-iqcc.bsky.social @chemotargets.com www.udg.edu/ca/instituts...

Check out our new article, Drug safety in healthy aging 🔎 www.nature.com/articles/s41... #longevity #lifespan #healthspan #drugsafety #healthyaging #polypharmacy

We are thrilled to announce that Jordi Mestres, our founder and CSO, has been chosen to join the #BioAngelsClub's Experts Committee. Congratulations! 🔝🚀 👉 bioangelsclub.com

Learn more about HTA & regulation in Drug Repurposing! Join the #iDR25 workshop series on 6 May in Amsterdam. Workshop 1️⃣: HTA—a key tool for patient access 🔧 Workshop 2️⃣: Navigating the regulatory path for repurposing 🗺️ Register here! ➡️ loom.ly/0sIBcrg

Check our latest work about Computational drug repurposing: approaches, evaluation of in silico resources and case studies by J Mestres in collaboration with Z Tanoli, T Aittokallio in @naturerevdrugdisc.bsky.social #NewPaperIQCC @dimocat-iqcc.bsky.social @univgirona.bsky.social bit.ly/4257K9b

Congratulations to Adrià Fernández-Torras, Ricard Garcia, and Jordi Mestres for their contribution to this comprehensive review on leveraging computational approaches for more effective and safer drug repurposing, published in Nature Reviews Drug Discovery. 🔝🚀 🔎 www.nature.com/articles/s41...

New article from the #R4All project on Computational drug repurposing 🔎 www.nature.com/articles/s41... Oustanding collection and evaluation of in silico resources and case studies on drug repurposing led by Dr. Tero Aittokallio. A privilege being part of this team! 👉 remedi4all.org/new-remedi4a...

NEW Patent Expansion Module in CIPsee 🔎 cipsee.com Unlock the full potential of patent molecules! Our proprietary generative chemistry method expands the chemical space around patented compounds. Curious about our developments in Chemical Intellectual Property? contact us at [email protected]!

A nice piece of work from our rising stars Luca Menestrina and Raquel Parrondo! 🔝 🔎 www.mdpi.com/1999-4923/17... Interested in generating novel small molecules for your new protein targets? Please contact us at [email protected]. #ADME #MLmodels #AIDD #generativechemistry #drugclasses

Last chance to save on your #iDR25 ticket! 🎟️Early Bird discounts close this Thursday – save substantially while securing your spot at #iDR25 - the International #DrugRepurposing Conference in Amsterdam this May. 👉Find out more & get your ticket here: remedi4all.org/2025-interna...

Our CSO, Jordi Mestres, will be attending 'Encuentros 2025' on February 21 in Granada, for an event dedicated to exploring the forefront of CRISPR, Advanced Cell Models, and the Future of Therapeutic Discover. www.medinadiscovery.com/es/abierto-p...